Abstract:Tong Chen, 1– 3 Shiquan Wu, 1 Ling Feng, 4 SiYu Long, 1 Yu Liu, 1, 2 WenQian Lu, 5 Wenya Chen, 1 Guoai Hong, 1 Li Zhou, 1 Fang Wang, 1 Yuechan Luo, 1 Hequn Zou 1, 3, 5 1 Department of Nephrology, South China Hospital of Shenzhen University, Shenzhen, People's Republic of China; 2 Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National Regional Key Technology Engineering Laboratory for Medical Ultrasound School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen, People's Republic of China; 3 Department of Nephrology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, People's Republic of China; 4 Department of Nephrology, Shenzhen Hospital, Southern Medical University, Shenzhen, People's Republic of China; 5 Department of Medicine, The Chinese University of Hong Kong, Shenzhen, People's Republic of China Correspondence: Hequn Zou, School of Medicine, The Chinese University of Hong Kong, Shenzhen, People's Republic of China, Email Background: The annual prevalence of metabolic syndrome (MetS) is increasing. Therefore, early screening and recognition of MetS are critical. This study aimed to evaluate the association between high-density lipoprotein (HDL) subclasses and MetS and to examine whether they could serve as early indicators in a Chinese community-based population with normal high-density lipoprotein cholesterol (HDL-C) levels. Methods: We used microfluidic chip technology to measure HDL subclasses in 463 people with normal HDL levels in 2018. We assessed how HDL subclasses correlated with and predicted insulin resistance (IR) and metabolic syndrome (MetS), evaluated by homeostatic model insulin resistance index (HOMA-IR) and the 2009 International Diabetes Federation (IDF), the American Heart Association (AHA), and the National Heart, Lung, and Blood Institute (NHLBI) criteria, respectively. We used correlation tests and ROC curves for the analysis. Results: The results indicate that there was a negative association between HDL2b% and the risk of IR and MetS in both sexes. Subjects in the highest quartile of HDL2b% had a significantly lower prevalence of IR and MetS than those in the lowest quartile (P< 0.01). Correlation analysis between HDL2b% and metabolic risk factors showed that HDL2b% had a stronger association with these factors than HDL-C did in both sexes. ROC curve analysis also showed that HDL2b% had significant diagnostic value for IR and MetS compared to other lipid indicators. Conclusion: This study showed that MetS alters the distribution of HDL subclasses even when HDL-C levels are within the normal range. HDL-2b% has better diagnostic value for IR and MetS than HDL-C alone and may be a useful marker for early screening. Keywords: HDL subclass, insulin resistance, metabolic syndrome, normal HDL-C population Metabolic syndrome (MetS) refers to a group of conditions that increases the risk of cardiovascular disease (CVD), stroke, and type 2 diabetes mellitus (T2DM). These conditions include insulin resistance (IR), elevated blood pressure, impaired glucose metabolism, abdominal obesity, elevated triglyceride levels, and low high-density lipoprotein cholesterol (HDL-C) concentrations. According to research, the global prevalence of MetS has increased over the last 20 years and global prevalence of MetS has been reported to be about 25%, causing huge health, social and economic burdens. 1,2 Therefore, early screening and recognition of MetS are of critical importance worldwide, especially in China, a society with high rates of overweight, dyslipidemia and CVD. 3 Although numerous clinical studies have described an inverse and independent relationship between HDL-C concentration and cardiovascular disease, 4–6 several large-scale studies have indicated that HDL-C levels may not always be associated with a lower risk of cardiovascular disease. 7–9 This has led to the suggestion that high-density lipoprotein (HDL) quality and functionality seem to be more important than HDL quantity (estimated by HDL-C) in reducing metabolic risk factors. 10 The HDL quality concerns the morphology and composition of the HDL, such as particle size, shape, number and the content of proteins, lipids, and RNAs. Moreover, The HDL quality is also associated with the extent of HDL modification, such as glycation and oxidation, which may impair the beneficial effects of HDL. 11 For example, previous studies have demonstrated that patients' blood may contain oxidatively modified lipoproteins, which may h -Abstract Truncated-

Lymphocyte to High-density Lipoprotein Cholesterol Ratio is Positively Associated with Pre-diabetes, Metabolic Syndrome, and Non-traditional Cardiometabolic Risk Markers: A Cross-sectional Study at Secondary Health Care

Clinical Usefulness Of Metabolic Risk Factors To Identify Young Asymptomatic Women Adults With Subclinical Atherosclerosis: A Cross-Sectional Study

Positive Relationship Between Serum Low-Density Lipoprotein Cholesterol Levels and Visceral Fat in a Chinese Nondiabetic Population.

Non-Traditional Blood Lipid Indices for Metabolism Dysfunction-Associated Fatty Liver Disease Prediction in Non-Obese Type 2 Diabetes Mellitus.

Predictive value of the relative lymphocyte count in coronary heart disease

Lymphocytes ≥ 2.9 (10 9 /L) in Newly Diagnosed Diabetes Are A Predictor of Future CVD Events

Lymphocytes≥2.9(109/L)in Newly Diagnosed Diabetes Are A Predictor of Future CVD Events

Inverse Relationship Between Serum Lipoxin A4 Level And The Risk Of Metabolic Syndrome In A Middle-Aged Chinese Population

Association Between Serum C-Peptide As A Risk Factor For Cardiovascular Disease And High-Density Lipoprotein Cholesterol Levels In Nondiabetic Individuals

Role of lymphocyte-to-monocyte ratio as a predictive marker for diabetic coronary artery disease: A cross-sectional study

Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid

The Association of HDL2b with Metabolic Syndrome Among Normal HDL-C Populations in Southern China

Associations of LDL-C-to-HDL-C and TG-to-HDL-C Ratios with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Prospective Cohort Study with 6 years’ Follow-Up

The association between lymphocyte to high‐density lipoprotein ratio and depression: Data from NHANES 2015–2018

Low HDL-C/ApoA-I index is associated with cardiometabolic risk factors and coronary artery calcium: a sub-analysis of the genetics of atherosclerotic disease (GEA) study

The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease

Monocyte to High-Density Lipoprotein Cholesterol Ratio at the Nexus of Type 2 Diabetes Mellitus Patients With Metabolic-Associated Fatty Liver Disease

HDL-C and non-HDL-C levels are associated with anthropometric and biochemical parameters

HDL-C criterion of the metabolic syndrome and future diabetes and atherosclerosis in midlife women: The SWAN Study

Triglyceride/high-density cholesterol ratio as a predictor of cardiometabolic risk in young population

The Role of Monocyte to High-Density Lipoprotein Cholesterol Ratio in Prediction of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes